Difference between revisions of "Lung Density Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
Line 39: Line 39:
  
 
* Phantom project
 
* Phantom project
 +
  
 
==Working Documents==
 
==Working Documents==
 
 
*[[Media:COPDDensityMatrix-V3.xls|COPD Density Matrix V3]]
 
*[[Media:COPDDensityMatrix-V3.xls|COPD Density Matrix V3]]
 
 
*[[Media:COPDMorphologyMatrix-V1.xls|COPD Morphology Matrix V1]]
 
*[[Media:COPDMorphologyMatrix-V1.xls|COPD Morphology Matrix V1]]
 
  
 
==Reference Documents==
 
==Reference Documents==

Revision as of 21:43, 12 December 2017

Co-chairs: Sean Fain, PhD; Matthew Fuld, PhD; David Lynch, MD
Secretary: Julie Lisiecki

Scope

Scope: Quantitative CT lung densitometry and morphology for COPD and related diseases.

Initial Objectives:

  • Characterize the precision and accuracy of phenotyping and progression measurements in emphysema and asthma.
This is an essential effort to classify phenotype and assess longitudinal changes as medically meaningful surrogates for health status.
  • Compare the sensitivity of CT measurements to spirometry and other accepted measures.
This will be necessary in order to determine if Progressive Disease can be detected significantly sooner with quantitative imaging techniques than with currently accepted methods.

Recent Meetings/Call Summaries

Lung Density/COPD BC Call Summaries Archive

Profile Development

Status - <summarize current status>

Archive - Lung Density

Protocol Development Activities


Groundwork Activities

Validate key concepts and answer key questions needed to write the Profiles and demonstrate their effectiveness.

  • Phantom project


Working Documents

Reference Documents

Round 2 of QIBA Funded Projects